Pediatric Pneumococcal Vaccine Study

Study Name:

Pediatric Pneumococcal Vaccine Study

Purpose:

Streptococcus pneumoniae, is a bacteria that causes pneumococcal disease. These infections can range from ear and sinus infections to blood infections, pneumonia, and meningitis. It is the most common bacterial cause of acute middle ear infections in children. Children under two years, are one of the age groups most vulnerable to this disease.

Description: Subjects 15- 24 months

The current pneumococcal vaccination protects children against 13 strains of the bacteria. Despite the wide availability of this vaccine, pneumococcal disease remains a concern due to other strains emerging. This is why an investigational vaccine is being researched to include the original 13 along with seven additional strains. We are looking at a 20-valent pneumococcal conjugate vaccine to help expand protection against pneumococcal disease beyond that covered by the current 13-valent pneumococcal vaccines in children. PriMed is looking for children 15- 24 months of age who have received their previous pneumococcal vaccinations in order to qualify.

What to Expect:

  • You will be asked to come into our research clinic for 2 visits. You will receive compensation for time and travel.
  • Your health as it relates to this study, will be evaluated at each appointment by our research coordinator and study doctor.
  • All study procedures will be at no cost to you or your insurance.
  • Our study team can coordinate with your primary physician to help you receive the most individualized care from our whole PriMED team.

 

Location: Primed Clinical Research Office
# Visit’s required: 2 office visits, 1 phone call
Reimbursement: $225
Brochure